HEADER TRANSFERASE 06-NOV-22 8BJT TITLE STRUCTURE OF HUMAN PLK1 IN COMPLEX WITH 2-ALLYL-1-[6-(1-HYDROXY-1- TITLE 2 METHYL-ETHYL)-PYRIDIN-2-YL]-6-[4-(4-METHYL-PIPERAZIN-1-YL)- TITLE 3 PHENYLAMINO]-1,2-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: POLO-LIKE KINASE 1,PLK-1,SERINE/THREONINE-PROTEIN KINASE 13, COMPND 5 STPK13; COMPND 6 EC: 2.7.11.21; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK1, PLK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PLK1, SELECTIVITY RESIDUES, KINASE, POLO-LIKE KINASE, STRUCTURE BASED KEYWDS 2 DRUG DESIGN, ATP-BINDING, NUCLEOTIDE-BINDING, PHOSPHORYLATION, KEYWDS 3 SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.MUSIL,L.LIU-BUJALSKI REVDAT 3 07-FEB-24 8BJT 1 REMARK REVDAT 2 31-MAY-23 8BJT 1 JRNL REVDAT 1 26-APR-23 8BJT 0 JRNL AUTH S.GULER,M.C.DIPOTO,A.CRESPO,R.CALDWELL,B.DOERFEL, JRNL AUTH 2 N.GROSSMANN,K.HO,B.HUCK,C.C.JONES,R.LAN,D.MUSIL,J.POTNICK, JRNL AUTH 3 H.SCHILKE,B.SHERER,S.SIMON,C.SIRRENBERG,Z.ZHANG, JRNL AUTH 4 L.LIU-BUJALSKI JRNL TITL SELECTIVE WEE1 INHIBITORS LED TO ANTITUMOR ACTIVITY IN VITRO JRNL TITL 2 AND CORRELATED WITH MYELOSUPPRESSION. JRNL REF ACS MED.CHEM.LETT. V. 14 566 2023 JRNL REFN ISSN 1948-5875 JRNL PMID 37197456 JRNL DOI 10.1021/ACSMEDCHEMLETT.2C00481 REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 35.2 REMARK 3 NUMBER OF REFLECTIONS : 7568 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.270 REMARK 3 FREE R VALUE TEST SET COUNT : 399 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.52 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 5.49 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 399 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2805 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 386 REMARK 3 BIN R VALUE (WORKING SET) : 0.2754 REMARK 3 BIN FREE R VALUE : 0.4419 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.26 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2365 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.24380 REMARK 3 B22 (A**2) : 1.24380 REMARK 3 B33 (A**2) : -2.48760 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.400 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.440 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2464 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3329 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 884 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 406 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2464 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 308 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1924 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.76 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.54 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -26.9116 22.7693 -9.6265 REMARK 3 T TENSOR REMARK 3 T11: -0.0631 T22: -0.1449 REMARK 3 T33: -0.1134 T12: -0.1105 REMARK 3 T13: -0.0256 T23: -0.0280 REMARK 3 L TENSOR REMARK 3 L11: 1.3568 L22: 0.9178 REMARK 3 L33: 6.0403 L12: -0.5323 REMARK 3 L13: 0.5889 L23: -0.2609 REMARK 3 S TENSOR REMARK 3 S11: 0.0186 S12: -0.0840 S13: -0.1154 REMARK 3 S21: -0.0344 S22: -0.3529 S23: -0.1661 REMARK 3 S31: 0.0380 S32: -0.4211 S33: 0.3343 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8BJT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1292126508. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAY-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99991 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7568 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.188 REMARK 200 RESOLUTION RANGE LOW (A) : 54.290 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.3 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.51 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2RKU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% W/V PEG4000, 0.1 M NA CITRATE PH REMARK 280 6.50, 0.6 M MG ACETATE, 0.0003 M ZN ACETATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 103.30867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 51.65433 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 51.65433 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 103.30867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 37 REMARK 465 LYS A 38 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 50 71.83 54.40 REMARK 500 LEU A 59 -64.40 -97.26 REMARK 500 ARG A 136 -133.81 61.36 REMARK 500 LYS A 146 -129.49 54.30 REMARK 500 ARG A 175 -10.00 72.42 REMARK 500 ASN A 185 -169.05 -77.77 REMARK 500 ASP A 194 70.04 55.69 REMARK 500 LEU A 286 75.73 -107.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 403 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 93 NE2 REMARK 620 2 CYS A 212 SG 102.3 REMARK 620 3 CYS A 255 SG 151.8 54.4 REMARK 620 N 1 2 DBREF 8BJT A 37 330 UNP P53350 PLK1_HUMAN 37 330 SEQADV 8BJT VAL A 210 UNP P53350 THR 210 CONFLICT SEQRES 1 A 294 ALA LYS GLU ILE PRO GLU VAL LEU VAL ASP PRO ARG SER SEQRES 2 A 294 ARG ARG ARG TYR VAL ARG GLY ARG PHE LEU GLY LYS GLY SEQRES 3 A 294 GLY PHE ALA LYS CYS PHE GLU ILE SER ASP ALA ASP THR SEQRES 4 A 294 LYS GLU VAL PHE ALA GLY LYS ILE VAL PRO LYS SER LEU SEQRES 5 A 294 LEU LEU LYS PRO HIS GLN ARG GLU LYS MET SER MET GLU SEQRES 6 A 294 ILE SER ILE HIS ARG SER LEU ALA HIS GLN HIS VAL VAL SEQRES 7 A 294 GLY PHE HIS GLY PHE PHE GLU ASP ASN ASP PHE VAL PHE SEQRES 8 A 294 VAL VAL LEU GLU LEU CYS ARG ARG ARG SER LEU LEU GLU SEQRES 9 A 294 LEU HIS LYS ARG ARG LYS ALA LEU THR GLU PRO GLU ALA SEQRES 10 A 294 ARG TYR TYR LEU ARG GLN ILE VAL LEU GLY CYS GLN TYR SEQRES 11 A 294 LEU HIS ARG ASN ARG VAL ILE HIS ARG ASP LEU LYS LEU SEQRES 12 A 294 GLY ASN LEU PHE LEU ASN GLU ASP LEU GLU VAL LYS ILE SEQRES 13 A 294 GLY ASP PHE GLY LEU ALA THR LYS VAL GLU TYR ASP GLY SEQRES 14 A 294 GLU ARG LYS LYS VAL LEU CYS GLY THR PRO ASN TYR ILE SEQRES 15 A 294 ALA PRO GLU VAL LEU SER LYS LYS GLY HIS SER PHE GLU SEQRES 16 A 294 VAL ASP VAL TRP SER ILE GLY CYS ILE MET TYR THR LEU SEQRES 17 A 294 LEU VAL GLY LYS PRO PRO PHE GLU THR SER CYS LEU LYS SEQRES 18 A 294 GLU THR TYR LEU ARG ILE LYS LYS ASN GLU TYR SER ILE SEQRES 19 A 294 PRO LYS HIS ILE ASN PRO VAL ALA ALA SER LEU ILE GLN SEQRES 20 A 294 LYS MET LEU GLN THR ASP PRO THR ALA ARG PRO THR ILE SEQRES 21 A 294 ASN GLU LEU LEU ASN ASP GLU PHE PHE THR SER GLY TYR SEQRES 22 A 294 ILE PRO ALA ARG LEU PRO ILE THR CYS LEU THR ILE PRO SEQRES 23 A 294 PRO ARG PHE SER ILE ALA PRO SER HET ACT A 401 4 HET 8X7 A 402 37 HET ZN A 403 1 HETNAM ACT ACETATE ION HETNAM 8X7 1-[6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-2-YL]-6-{[4-(4- HETNAM 2 8X7 METHYLPIPERAZIN-1-YL)PHENYL]AMINO}-2-(PROP-2-EN-1-YL)- HETNAM 3 8X7 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE HETNAM ZN ZINC ION FORMUL 2 ACT C2 H3 O2 1- FORMUL 3 8X7 C27 H32 N8 O2 FORMUL 4 ZN ZN 2+ FORMUL 5 HOH *22(H2 O) HELIX 1 AA1 SER A 87 LEU A 89 5 3 HELIX 2 AA2 LYS A 91 ARG A 106 1 16 HELIX 3 AA3 SER A 137 LYS A 146 1 10 HELIX 4 AA4 THR A 149 ASN A 170 1 22 HELIX 5 AA5 LYS A 178 GLY A 180 5 3 HELIX 6 AA6 ALA A 219 SER A 224 1 6 HELIX 7 AA7 PHE A 230 GLY A 247 1 18 HELIX 8 AA8 CYS A 255 ASN A 266 1 12 HELIX 9 AA9 ASN A 275 LEU A 286 1 12 HELIX 10 AB1 ASP A 289 ARG A 293 5 5 HELIX 11 AB2 GLU A 298 ASN A 301 5 4 HELIX 12 AB3 ASP A 302 SER A 307 1 6 HELIX 13 AB4 PRO A 315 THR A 320 5 6 SHEET 1 AA1 6 VAL A 43 ASP A 46 0 SHEET 2 AA1 6 ARG A 51 GLY A 62 -1 O TYR A 53 N LEU A 44 SHEET 3 AA1 6 ALA A 65 ASP A 72 -1 O SER A 71 N VAL A 54 SHEET 4 AA1 6 VAL A 78 PRO A 85 -1 O PHE A 79 N ILE A 70 SHEET 5 AA1 6 PHE A 125 GLU A 131 -1 O LEU A 130 N ALA A 80 SHEET 6 AA1 6 PHE A 116 GLU A 121 -1 N PHE A 120 O PHE A 127 SHEET 1 AA2 2 VAL A 172 ILE A 173 0 SHEET 2 AA2 2 THR A 199 LYS A 200 -1 O THR A 199 N ILE A 173 SHEET 1 AA3 2 LEU A 182 LEU A 184 0 SHEET 2 AA3 2 VAL A 190 ILE A 192 -1 O LYS A 191 N PHE A 183 LINK NE2 HIS A 93 ZN ZN A 403 1555 1555 2.33 LINK SG CYS A 212 ZN ZN A 403 1555 1555 2.18 LINK SG CYS A 255 ZN ZN A 403 1555 6554 2.73 CRYST1 66.932 66.932 154.963 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014941 0.008626 0.000000 0.00000 SCALE2 0.000000 0.017252 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006453 0.00000